: SDS-PAGE and anti-acetylated lysine antibody Western blot of beta2GPI after acetylation with different molar ratios of NHS-Ac/lysine. Figure S2 : Quantitative shape analysis after AFM imaging of beta2GPI acetylated with different molar ratios of NHS-Ac/lysine. Figure S1 : A) Reductive SDS-PAGE of beta2GPI after acetylation with different molar ratios of NHS-Ac to lysine residues. Lane 1 to 5 refer to dimethylformamide (DMF) treatment, as well as ratios of 1, 10, 100, and 1,000 NHS-Ac/lysine (mol/mol), respectively. Lane 6 describes the untreated beta2GPI. On the very left side a protein molecular weight standard is shown. B) Corresponding anti-acetylated lysine antibody Western blot of beta2GPI after acetylation at different NHS-Ac/lysine ratios. Lanes are the same as described in B. The bands corresponding to acetylated lysine residues of beta2GPI are highlighted by arrows.
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